In the context of Alzheimer’s disease, this refined view suggests that impaired redox signaling—rather than simply ROS overproduction—contributes to amyloid-β aggregation, tau hyperphosphorylation, mitochondrial dysfunction, and neuroinflammation. This evidence concerns the gene MAPT and Alzheimer disease.